Home › NDC Lookup › RxCUI directory › RxCUI 833141

Milnacipran hydrochloride 12.5 MG Oral Tablet — RxCUI 833141

RxNorm drug concept · Semantic clinical drug
RxCUI 833141 Semantic clinical drug · SCD ● Current RxNorm concept 18 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI833141
Official nameMilnacipran hydrochloride 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmilnacipran HCl 12.5 MG Oral Tablet
FDA products mapped18
Package NDCs mapped22
Reported Medicaid activity (SDUD)28,086 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Milnacipran: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question, because it's a common source of confusion. Milnacipran belongs to a class of drugs called SNRIs, which are also used to treat depression — but milnacipran itself is...
  • What exactly is milnacipran used for — is it an antidepressant?
  • Yes, nausea is the most common side effect, but there's a practical tip: try taking your tablet with food. The label specifically notes that taking milnacipran with food can help i...
  • Nausea seems really common with this medication — is there anything I can do about it?
📖 Read our full Milnacipran guide →

🕸️ Concept Web — How Milnacipran hydrochloride 12.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Milnacipran hydrochloride 12.5 MG Oral Tablet RxCUI 833141

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Milnacipran 588250
    • Milnacipran hydrochloride 30003
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Savella 833136
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Milnacipran Oral Tablet 833134
    • Milnacipran hydrochloride Oral Tablet 2646511
    • Milnacipran Oral Product 1157278
    • Milnacipran Pill 1157279
    • Milnacipran hydrochloride Oral Product 2659821
    • Milnacipran hydrochloride Pill 2660203
    • Milnacipran Oral Tablet [Savella] 833138
    • Milnacipran hydrochloride Oral Tablet [Savella] 2656132
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 16 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

18 products · 22 package NDCs
22 package NDCs map to RxCUI 833141 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00456-1500-55 1 BLISTER PACK in 1 CARTON (0456-1500-55) / 1 KIT in 1 BLIS... Savella Allergan, Inc. 2009-04-17
00456-1510-60 60 TABLET, FILM COATED in 1 BOTTLE (0456-1510-60) Savella Allergan, Inc. 2009-04-17
00456-1512-60 60 TABLET, FILM COATED in 1 BOTTLE (0456-1512-60) Savella Allergan, Inc. 2009-04-17
00456-1525-60 60 TABLET, FILM COATED in 1 BOTTLE (0456-1525-60) Savella Allergan, Inc. 2009-04-17
00456-1550-60 60 TABLET, FILM COATED in 1 BOTTLE (0456-1550-60) Savella Allergan, Inc. 2009-04-17
31722-0846-32 10 BLISTER PACK in 1 CARTON (31722-846-32) / 10 TABLET, FIL... MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0846-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-846-60) MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0847-32 10 BLISTER PACK in 1 CARTON (31722-847-32) / 10 TABLET, FIL... MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0847-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-847-60) MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0848-32 10 BLISTER PACK in 1 CARTON (31722-848-32) / 10 TABLET, FIL... MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0848-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-848-60) MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0849-32 10 BLISTER PACK in 1 CARTON (31722-849-32) / 10 TABLET, FIL... MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0849-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-849-60) MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
31722-0880-31 1 KIT in 1 BLISTER PACK (31722-880-31) MILNACIPRAN HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-19
51991-0034-06 60 TABLET in 1 BOTTLE (51991-034-06) Milnacipran Hydrochloride Breckenridge Pharmaceutical, Inc. 2026-03-19
51991-0036-06 60 TABLET in 1 BOTTLE (51991-036-06) Milnacipran Hydrochloride Breckenridge Pharmaceutical, Inc. 2026-03-19
51991-0037-06 60 TABLET in 1 BOTTLE (51991-037-06) Milnacipran Hydrochloride Breckenridge Pharmaceutical, Inc. 2026-03-19
51991-0876-06 60 TABLET in 1 BOTTLE (51991-876-06) Milnacipran Hydrochloride Breckenridge Pharmaceutical, Inc. 2026-03-19
68462-0763-60 60 TABLET, FILM COATED in 1 BOTTLE (68462-763-60) Milnacipran Hydrochloride Glenmark Pharmaceuticals Inc., USA 2026-03-19
68462-0764-60 60 TABLET, FILM COATED in 1 BOTTLE (68462-764-60) Milnacipran Hydrochloride Glenmark Pharmaceuticals Inc., USA 2026-03-19
68462-0765-60 60 TABLET, FILM COATED in 1 BOTTLE (68462-765-60) Milnacipran Hydrochloride Glenmark Pharmaceuticals Inc., USA 2026-03-19
68462-0766-60 60 TABLET, FILM COATED in 1 BOTTLE (68462-766-60) Milnacipran Hydrochloride Glenmark Pharmaceuticals Inc., USA 2026-03-19
Observed labelers: Camber Pharmaceuticals, Inc. (9) · Allergan, Inc. (5) · Breckenridge Pharmaceutical, Inc. (4) · Glenmark Pharmaceuticals Inc., USA (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.